These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11983450)

  • 1. Acyclic retinoid induces partial differentiation, down-regulates telomerase reverse transcriptase mRNA expression and telomerase activity, and induces apoptosis in human hepatoma-derived cell lines.
    Yasuda I; Shiratori Y; Adachi S; Obora A; Takemura M; Okuno M; Shidoji Y; Seishima M; Muto Y; Moriwaki H
    J Hepatol; 2002 May; 36(5):660-71. PubMed ID: 11983450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis induction by acyclic retinoid: a molecular basis of 'clonal deletion' therapy for hepatocellular carcinoma.
    Okuno M; Sano T; Matsushima-Nishiwaki R; Adachi S; Akita K; Okano Y; Kojima S; Moriwaki H
    Jpn J Clin Oncol; 2001 Aug; 31(8):359-62. PubMed ID: 11574627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of serum lectin-reactive alpha-fetoprotein by acyclic retinoid: a potent biomarker in the chemoprevention of second primary hepatoma.
    Moriwaki H; Yasuda I; Shiratori Y; Uematsu T; Okuno M; Muto Y
    Clin Cancer Res; 1997 May; 3(5):727-31. PubMed ID: 9815742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic induction of apoptosis by acyclic retinoid and interferon-beta in human hepatocellular carcinoma cells.
    Obora A; Shiratori Y; Okuno M; Adachi S; Takano Y; Matsushima-Nishiwaki R; Yasuda I; Yamada Y; Akita K; Sano T; Shimada J; Kojima S; Okano Y; Friedman SL; Moriwaki H
    Hepatology; 2002 Nov; 36(5):1115-24. PubMed ID: 12395321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The enzymatic basis for the conversion of nonfucosylated to fucosylated alpha-fetoprotein by acyclic retinoid treatment in human hepatoma cells: activation of alpha1-6 fucosyltransferase.
    Noda K; Miyoshi E; Kitada T; Nakahara S; Gao CX; Honke K; Shiratori Y; Moriwaki H; Sasaki Y; Kasahara A; Hori M; Hayashi N; Taniguchi N
    Tumour Biol; 2002; 23(4):202-11. PubMed ID: 12499776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effects of acyclic retinoid and OSI-461 on growth inhibition and gene expression in human hepatoma cells.
    Shimizu M; Suzui M; Deguchi A; Lim JT; Xiao D; Hayes JH; Papadopoulos KP; Weinstein IB
    Clin Cancer Res; 2004 Oct; 10(19):6710-21. PubMed ID: 15475462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomerase activity in human hepatocellular carcinoma: parallel correlation with human telomerase reverse transcriptase (hTERT) mRNA isoform expression but not with cell cycle modulators or c-Myc expression.
    Chen CJ; Tsai NM; Liu YC; Ho LI; Hsieh HF; Yen CY; Harn HJ
    Eur J Surg Oncol; 2002 Apr; 28(3):225-34. PubMed ID: 11944954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of apoptosis by acyclic retinoid in the human hepatoma-derived cell line, HuH-7.
    Nakamura N; Shidoji Y; Yamada Y; Hatakeyama H; Moriwaki H; Muto Y
    Biochem Biophys Res Commun; 1995 Feb; 207(1):382-8. PubMed ID: 7857292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acyclic retinoid, a novel synthetic retinoid, induces growth inhibition, apoptosis, and changes in mRNA expression of cell cycle- and differentiation-related molecules in human colon carcinoma cells.
    Suzui M; Sunagawa N; Chiba I; Moriwaki H; Yoshimi N
    Int J Oncol; 2006 May; 28(5):1193-9. PubMed ID: 16596235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of acyclic retinoid (polyprenoic acid) and its hydroxy derivative on cell growth and on secretion of alpha-fetoprotein in human hepatoma-derived cell line (PLC/PRF/5).
    Fukutomi Y; Omori M; Muto Y; Ninomiya M; Okuno M; Moriwaki H
    Jpn J Cancer Res; 1990 Dec; 81(12):1281-5. PubMed ID: 1703522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual induction of caspase 3- and transglutaminase-dependent apoptosis by acyclic retinoid in hepatocellular carcinoma cells.
    Tatsukawa H; Sano T; Fukaya Y; Ishibashi N; Watanabe M; Okuno M; Moriwaki H; Kojima S
    Mol Cancer; 2011 Jan; 10():4. PubMed ID: 21214951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoids induced astrocytic differentiation with down regulation of telomerase activity and enhanced sensitivity to taxol for apoptosis in human glioblastoma T98G and U87MG cells.
    Das A; Banik NL; Ray SK
    J Neurooncol; 2008 Mar; 87(1):9-22. PubMed ID: 17987264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis in human hepatoma cell line induced by 4,5-didehydro geranylgeranoic acid (acyclic retinoid) via down-regulation of transforming growth factor-alpha.
    Nakamura N; Shidoji Y; Moriwaki H; Muto Y
    Biochem Biophys Res Commun; 1996 Feb; 219(1):100-4. PubMed ID: 8619789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms of the combination of retinoid and interferon-gamma for inducing differentiation and increasing apoptosis in human glioblastoma T98G and U87MG cells.
    Das A; Banik NL; Ray SK
    Neurochem Res; 2009 Jan; 34(1):87-101. PubMed ID: 18368485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation effect of acyclic retinoid on acute promyelocytic leukemia cells.
    Usuki K; Urabe A; Tojo A; Moriwaki H; Tsurumi H; Ikeda Y; Kizaki M; Toyama K; Aizawa M; Inai K; Muto Y; Asano S; Takaku F
    Ann Hematol; 1996 Nov; 73(5):219-24. PubMed ID: 8959939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acyclic retinoid induces differentiation and apoptosis of murine hepatic stem cells.
    Guan HB; Nie YZ; Zheng YW; Takiguchi K; Yu HW; Zhang RR; Li B; Tsuchida T; Taniguchi H
    Stem Cell Res Ther; 2015 Mar; 6(1):51. PubMed ID: 25881300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative splicing of human telomerase reverse transcriptase may not be involved in telomerase regulation during all-trans-retinoic acid-induced HL-60 cell differentiation.
    Liu WJ; Zhang YW; Zhang ZX; Ding J
    J Pharmacol Sci; 2004 Oct; 96(2):106-14. PubMed ID: 15467265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of cell growth and telomerase activity of breast cancer cells in vitro by retinoic acids.
    Choi SH; Kang HK; Im EO; Kim YJ; Bae YT; Choi YH; Lee KH; Chung HY; Chang HK; Kim ND
    Int J Oncol; 2000 Nov; 17(5):971-6. PubMed ID: 11029500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomerase reverse transcriptase suppression inhibits cell proliferation and promotes cell apoptosis in hepatocellular cancer.
    Shen Y; Xi F; Li H; Luo Y; Chen C; Wang L
    IUBMB Life; 2018 Jul; 70(7):642-648. PubMed ID: 29707886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic down-regulation of telomerase activity and hTERT mRNA expression by combination of retinoic acid and GM-CSF in human myeloblastic leukemia ML-1 cells.
    Mano Y; Shimizu T; Tanuma S; Takeda K
    Anticancer Res; 2000; 20(3A):1649-52. PubMed ID: 10928085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.